Why could the US stock market fall this week? PCE inflation and GDP data could shake the S&P 500 and Nasdaq. Here's what ...

AML3D (ASX:AL3) wins a ~A$2.2m ARCEMY X order from Northrop Grumman, its first US Navy prime customer win in a growing ...

Metallium (ASX:MTM) signs a non-binding MOU with US$10bn commodity trader Traxys to commercialise its US critical metals ...

Cochlear (ASX:COH) reaffirmed FY27 profit guidance of $330m to $350m at today's AGM after a soft FY26 and a reset of the ...

Pureprofile (ASX:PPL) posted record Q1 FY27 revenue of A$18.3m as Platform revenue doubled and EBITDA margin expanded to 13%.

Genmab (NDQ:GMAB) enters FY26 as one of the most profitable royalty engines in global oncology. The company’s antibody ...

United Therapeutics (NDQ:UNTR) is the only listed company attempting to industrialise the supply of transplantable organs.

Tuas (ASX:TUA) plunged after Singapore's IMDA escalated its Simba probe, raising the risk of spectrum restrictions, fines and licence action.

Verizon (VZ) reports Q3 earnings Monday as SpaceX eyes 80,000 US cell sites. See Wall Street forecasts and what could move ...

Zip Co (ASX:ZIP) reconfirmed FY27 cash EBTDA guidance of A$340m after a US$7.2m US fraud event and 34% US TTV growth in 1Q27.

BHP (ASX:BHP) copper production fell 19% in Q1 FY27, but bulk commodities, record WAIO output and the Jansen build steady the ...

Temple & Webster (ASX:TPW) guided FY27 EBITDA to A$33-40m at its AGM, up 50-80%, as margin discipline and private label ...